Dolby Laboratories Inc

Dolby Laboratories Inc (DLB) Stock Analysis

$61.500

-0.898 (-1.46%)At close

Loading chart…
High
62.655
Open
62.090
VWAP
61.46
Vol
1.71M
Mkt Cap
7.60B
Low
60.230
Amount
105.26M
EV/EBITDA, TTM
18.17

Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The two primary components of its licensing business are Branded Technologies, which include Branded Audio Codecs, Dolby Atmos & Dolby Vision, and Patents, which include Audio Patents and Imaging Patents. The Company's cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. It also offers various services to support theatrical and television production for cinema, broadcast, and home entertainment.

www.dolby.com

AI analysis of Dolby Laboratories Inc (DLB)

hold

Currently, Dolby Laboratories Inc is not a strong buy. The stock is trading at $61.50, with a low RSI of 35.711 indicating it is oversold. However, insider selling has increased by 1552.33%, which raises concerns about the company's internal confidence. The forward P/E ratio of 14.1243 suggests potential value, but the recent performance shows a 5-day decline of 5.78%, indicating bearish momentum.

Analyst Ratings (7)

+42.28% upside
Buy
5 Buy
2 Hold
0 Sell
Current: 61.50
Low
85.00
Average
87.50
High
90.00

Baird

2025-09-05

Price Target

$74

Neutral

Baird

2025-09-04

Price Target

$74

Neutral

Tigress Financial

2025-08-15

Price Target

$114

Buy

Barrington Research

2025-02-13

Price Target

$100

Buy

Rosenblatt

2025-01-30

Price Target

$100

Strong Buy

Valuation Metrics

The current forward P/E ratio for Dolby Laboratories Inc (DLB) is 14.12, compared to its 5-year average forward P/E of 20.34.

Forward P/E

Undervalued
5Y Average P/E
20.34
Current P/E
14.12
Overvalued
23.86
Undervalued
16.82

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
13.64
Current EV/EBITDA
18.17
Overvalued
15.69
Undervalued
11.58

Forward P/S

Undervalued
5Y Average P/S
5.45
Current P/S
3.98
Overvalued
6.33
Undervalued
4.58

Alphio AI Price Scenarios for DLB

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%DLB

$93.42

Scenario price

B

Base

Base · 50%DLB

$91.04

Scenario price

B

Bear

Bear · 25%DLB

$83.76

Scenario price

Whales holding DLB

S

Snyder Capital Management, L.P.

+ HoldingDLB

+5.37%

3M Return

Events Timeline

2026-08-27 (ET)

09:31:00

Dolby Laboratories Appoints Marc Whitten as New CEO

2026-08-21 (ET)

06:00:00

Cinemo Partners with Dolby to Launch In-Car Music Gaming

2026-07-30 (ET)

16:30:00

Dolby Laboratories Reports Q3 Revenue of $305M

16:30:00

Dolby Board Approves $350M Increase in Buyback Program

2026-04-30 (ET)

20:10:00

Atlassian Rises 23.8% After Earnings

News

DLB FAQ — answered by Alphio AI

Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The two primary components of its licensing business are Branded Technologies, which include Branded Audio Codecs, Dolby Atmos & Dolby Vision, and Patents, which include Audio Patents and Imaging Patents. The Company's cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. It also offers various services to support theatrical and television production for cinema, broadcast, and home entertainment. It operates in the Technology sector (PATENT OWNERS & LESSORS industry).

Currently, Dolby Laboratories Inc is not a strong buy. The stock is trading at $61.50, with a low RSI of 35.711 indicating it is oversold. However, insider selling has increased by 1552.33%, which raises concerns about the company's internal confidence. The forward P/E ratio of 14.1243 suggests potential value, but the recent performance shows a 5-day decline of 5.78%, indicating bearish momentum.

7 analysts cover DLB: 5 rate it Buy, 2 Hold and 0 Sell. The average price target is 87.50.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started